256 related articles for article (PubMed ID: 16627920)
1. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
Thompson LD; Wieneke JA; Heffess CS
Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
[TBL] [Abstract][Full Text] [Related]
2. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
3. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
Lam AK; Lo CY
Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
[TBL] [Abstract][Full Text] [Related]
5. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
Chang WC; Chen JY; Lee CH; Yang AH
Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
7. Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid.
Imamura Y; Kasahara Y; Fukuda M
Endocr Pathol; 2000; 11(1):97-108. PubMed ID: 15304844
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
[TBL] [Abstract][Full Text] [Related]
9. Diffuse sclerosing variant of papillary thyroid carcinoma--clinical features and outcome.
Chow SM; Chan JK; Law SC; Tang DL; Ho CM; Cheung WY; Wong IS; Lau WH
Eur J Surg Oncol; 2003 Jun; 29(5):446-9. PubMed ID: 12798749
[TBL] [Abstract][Full Text] [Related]
10. Thyroglossal Duct Cyst Carcinomas: A Clinicopathologic Series of 22 Cases with Staging Recommendations.
Thompson LDR; Herrera HB; Lau SK
Head Neck Pathol; 2017 Jun; 11(2):175-185. PubMed ID: 27704385
[TBL] [Abstract][Full Text] [Related]
11. Diffuse intrathyroidal dissemination of papillary thyroid carcinoma with no stromal fibrosis at presentation: A pattern of aggressive differentiated thyroid carcinoma.
Fang H; Si Y; Wang C; Gong Q; Liu C; Wang S
Pathol Res Pract; 2021 Aug; 224():153510. PubMed ID: 34329840
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
[TBL] [Abstract][Full Text] [Related]
13. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.
Kuo EJ; Goffredo P; Sosa JA; Roman SA
Thyroid; 2013 Oct; 23(10):1305-11. PubMed ID: 23600998
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.
Fukushima M; Ito Y; Hirokawa M; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):958-62. PubMed ID: 19198928
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.
Lim JY; Hong SW; Lee YS; Kim BW; Park CS; Chang HS; Cho JY
Thyroid; 2013 Nov; 23(11):1423-30. PubMed ID: 23496275
[TBL] [Abstract][Full Text] [Related]
16. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
[TBL] [Abstract][Full Text] [Related]
17. Cytomorphologic features of diffuse sclerosing variant of papillary carcinoma of the thyroid. A report of two cases in children.
Kumarasinghe MP
Acta Cytol; 1998; 42(4):983-6. PubMed ID: 9684590
[TBL] [Abstract][Full Text] [Related]
18. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases.
Carcangiu ML; Bianchi S
Am J Surg Pathol; 1989 Dec; 13(12):1041-9. PubMed ID: 2490923
[TBL] [Abstract][Full Text] [Related]
19. Diffuse sclerosing variant of papillary thyroid carcinoma: a study of fine needle aspiration cytology in 20 patients.
Takagi N; Hirokawa M; Nobuoka Y; Higuchi M; Kuma S; Miyauchi A
Cytopathology; 2014 Jun; 25(3):199-204. PubMed ID: 23781895
[TBL] [Abstract][Full Text] [Related]
20. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
